Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY. |  |
|
|
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Dolsten Mikael | Former Officer | May 23 '25 | Proposed Sale | 23.09 | 59,781 | 1,380,632 | | May 23 10:54 AM | Dolsten Mikael | Former Officer | May 05 '25 | Proposed Sale | 23.87 | 55,000 | 1,312,736 | | May 05 04:45 PM | DAMICO JENNIFER B. | SVP & Controller | Mar 04 '25 | Sale | 25.93 | 2,500 | 64,825 | 11,850 | Mar 06 01:57 PM | DAMICO JENNIFER B. | SVP & Controller | Feb 27 '25 | Option Exercise | 31.31 | 22,416 | 701,845 | 31,063 | Mar 03 05:39 PM | SUSMAN SALLY | Executive Vice President | Feb 27 '25 | Option Exercise | 31.31 | 85,182 | 2,667,048 | 250,866 | Mar 03 05:38 PM | SAHNI PAYAL | Executive Vice President | Feb 27 '25 | Option Exercise | 31.31 | 19,054 | 596,581 | 44,242 | Mar 03 05:38 PM | McDermott Michael | Executive Vice President | Feb 27 '25 | Option Exercise | 31.31 | 48,419 | 1,515,999 | 122,413 | Mar 03 05:37 PM | LANKLER DOUGLAS M | Executive Vice President | Feb 27 '25 | Option Exercise | 31.31 | 156,914 | 4,912,977 | 309,790 | Mar 03 05:37 PM | Fonseca Lidia | Executive Vice President | Feb 27 '25 | Option Exercise | 31.31 | 72,629 | 2,274,014 | 111,534 | Mar 03 05:36 PM | BOURLA ALBERT | Chairman & CEO | Feb 27 '25 | Option Exercise | 31.31 | 582,823 | 18,248,188 | 931,744 | Mar 03 05:36 PM | McDermott Michael | Executive Vice President | Feb 22 '25 | Option Exercise | 30.17 | 11,125 | 335,641 | 87,636 | Feb 25 07:38 PM | DAMICO JENNIFER B. | SVP & Controller | Feb 22 '25 | Option Exercise | 30.17 | 8,741 | 263,716 | 17,602 | Feb 25 07:38 PM | BOURLA ALBERT | Chairman & CEO | Feb 22 '25 | Option Exercise | 30.17 | 238,399 | 7,192,498 | 570,436 | Feb 25 07:06 PM | LANKLER DOUGLAS M | Executive Vice President | Feb 22 '25 | Option Exercise | 30.17 | 85,824 | 2,589,310 | 232,775 | Feb 25 07:05 PM | SAHNI PAYAL | Executive Vice President | Feb 22 '25 | Option Exercise | 30.17 | 12,714 | 383,581 | 37,099 | Feb 25 07:04 PM | SUSMAN SALLY | Executive Vice President | Feb 22 '25 | Option Exercise | 30.17 | 63,573 | 1,917,997 | 225,184 | Feb 25 07:02 PM | BOSHOFF CHRISTOFFEL | President, R&D | Feb 22 '25 | Option Exercise | 30.17 | 8,741 | 263,716 | 159,085 | Feb 25 06:58 PM | BLAYLOCK RONALD E | Director | Feb 13 '25 | Buy | 25.65 | 19,457 | 499,072 | 27,707 | Feb 14 05:16 PM | Gottlieb Scott | Director | Oct 30 '24 | Buy | 28.24 | 1,000 | 28,240 | 10,000 | Oct 31 04:06 PM | DAMICO JENNIFER B. | SVP & Controller | Aug 13 '24 | Sale | 28.66 | 5,154 | 147,714 | 8,582 | Aug 14 03:47 PM |
|